| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Submitted on December 21, 2005
Accepted on April 13, 2006
Institute of Neuroscience and Physiology/Endocrinology, Sahlgrenska Academy, Göteborg University, SE 405 30 Göteborg, Sweden; Center for bone research at the Sahlgrenska Academy, Sahlgrenska University Hospital and Sahlgrenska Academy, SE-413 45 Göteborg, Sweden; Swegene Bioinformatics, Göteborg University, SE 405 30 Göteborg, Sweden
* To whom correspondence should be addressed. E-mail: JOJ{at}medic.gu.se.
Context: There is growing evidence for interactions between the regulation of body fat and the immune system. Studies of knockout mice indicate that IL-1 has an anti-obesity effect.
Objective: To investigate our hypothesis that common polymorphisms of the IL-1 system, which are associated with IL-1 activity, also are associated with fat mass.
Design, Setting and Study Subjects: The Gothenburg Osteoporosis and Obesity Determinants (GOOD) study is a population-based cross-sectional study of 18-20 yr old men (n = 1068), mostly Caucasian, from the Gothenburg area (Sweden). Three different polymorphisms, IL-1
+3953 C/T, IL-1
-31 T/C, and IL-1 receptor antagonist (IL-1RN) variable number tandem repeat (VNTR) of 86 bp, were investigated in relation to body fat mass.
Main Outcome Measure: The main outcome measures were genotype distributions and their association with body fat mass in different compartments, measured with Dual energy x-ray Absorptiometry (DXA).
Results: Carriers of the T variant (CT and TT) of the +3953 C to T (FT=0.25) IL-1
gene polymorphism had significantly lower total fat mass (P = 0.013) and also significantly reduced arm, leg, and trunk fat compared with CC individuals. IL-1RN*2 carriers with two repeats of the IL-1RN VNTR polymorphism had increased total fat (P = 0.036), serum leptin, fat of trunk and arm, as well as serum levels of IL-1RN and IL-1RN production ex vivo. The IL-1
-31 polymorphism did not correlate with the fat measurements.
Conclusions: The IL-1 system, recently shown to affect fat mass in experimental animals, contains gene polymorphisms that are associated with fat mass in young men.
This article has been cited by other articles:
![]() |
J. Shen, D. K. Arnett, J. M. Peacock, L. D. Parnell, A. Kraja, J. E. Hixson, M. Y. Tsai, C.-Q. Lai, E. K. Kabagambe, R. J. Straka, et al. Interleukin1{beta} Genetic Polymorphisms Interact with Polyunsaturated Fatty Acids to Modulate Risk of the Metabolic Syndrome J. Nutr., August 1, 2007; 137(8): 1846 - 1851. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |